Gender Incongruence
Conditions
Interventions
Case group:NA
Sponsors
Beijing Huilongguan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
6 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age >= 6 years, no gender restrictions; 2. Meets the diagnostic criteria for gender incongruence according to ICD-11; 3. Does not currently meet the diagnostic criteria for any other mental disorder according to DSM-5, such as depressive disorder, bipolar disorder, schizophrenia, anxiety disorders, post-traumatic stress disorder, etc.; 4. Able to understand and cooperate with the research procedures; 5. Understands and voluntarily participates in this study, with informed consent signed by the participant or their legal guardian.
Exclusion criteria
Exclusion criteria: 1.Based on the investigator's clinical judgment and/or the C-SSRS, the participant has had suicidal ideation with some intent to act within the 6 months prior to screening (i.e., a "Yes" answer to item 4 [active suicidal ideation with some intent to act, without specific plan] or item 5 [active suicidal ideation with specific plan and intent] of the C-SSRS), or has had a history of suicidal behavior within the year prior to screening. 2. Other conditions deemed inappropriate for participation in this study as assessed by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hamilton Depression Scale (HAMD-17);Hamilton Anxiety Rating Scale (HAMA);Self-Rating Depression Scale (SDS);Self-Rating Anxiety Scale (SAS);Patient Health Questionnaire-9 (PHQ-9);Generalized Anxiety Disorder Scale (GAD-7); | — |
Secondary
| Measure | Time frame |
|---|---|
| Eysenck Personality Questionaire-Revised ,Short Scale For Chinese (EPQ-RSC));Perceived Social Support Scale (PSSS);Dysfunctional Attitude Scale (DAS);Revision of the Short-form Egna Minnen av Barndoms Uppfostran for Chinese (s-EMBU-C);Parental Psychological Control Scale (PPCS);Defense Style Questionnaire (DSQ);Average Heart Rate;Minimum Heart Rate;Maximum Heart Rate;Follicle-Stimulating Hormone (FSH);Luteinizing Hormone (LH);Estradiol (E2);Testosterone;Progesterone;Prolactin (PRL); | — |
Countries
China
Contacts
Public ContactXiaohong Li/Xinpeng Xu
Beijing Huilongguan Hospital, Capital Medical University
Outcome results
None listed